Invention Grant
- Patent Title: Pyrrolotriazine kinase inhibitors
- Patent Title (中): 吡咯并三嗪激酶抑制剂
-
Application No.: US12920511Application Date: 2009-03-04
-
Publication No.: US08212031B2Publication Date: 2012-07-03
- Inventor: Upender Velaparthi , Dolatrai M. Vyas
- Applicant: Upender Velaparthi , Dolatrai M. Vyas
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Elliott Korsen
- International Application: PCT/US2009/035975 WO 20090304
- International Announcement: WO2009/111531 WO 20090911
- Main IPC: C07D253/08
- IPC: C07D253/08
Abstract:
The invention provides compounds of formula I and pharmaceutically acceptable salts thereof. The formula I compounds inhibit protein kinase activity thereby making them useful as anticancer agents.
Public/Granted literature
- US20110003821A1 PYRROLOTRIAZINE KINASE INHIBITORS Public/Granted day:2011-01-06
Information query
